Cargando…
Enhancing the Promise of Drug Repositioning through Genetics
The development of new drugs has become challenging as the necessary investments in time and money have increased while drug approval rates have decreased. A potential solution to this problem is drug repositioning which aims to use existing drugs to treat conditions for which they were not original...
Autores principales: | Pritchard, Jayne-Louise E., O’Mara, Tracy A., Glubb, Dylan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724196/ https://www.ncbi.nlm.nih.gov/pubmed/29270124 http://dx.doi.org/10.3389/fphar.2017.00896 |
Ejemplares similares
-
Editorial: Establishing Genetic Pleiotropy to Identify Common Pharmacological Agents for Common Diseases
por: O’Mara, Tracy A., et al.
Publicado: (2019) -
The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?
por: Glubb, Dylan M., et al.
Publicado: (2017) -
Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment
por: Menduti, Giovanna, et al.
Publicado: (2020) -
10 Years of GWAS discovery in endometrial cancer: Aetiology, function and translation
por: Wang, Xuemin, et al.
Publicado: (2022) -
Dietary Factors and Endometrial Cancer Risk: A Mendelian Randomization Study
por: Wang, Xuemin, et al.
Publicado: (2023)